- Penfluridol for schizophrenia
- Perazine for schizophrenia
- Perphenazine for schizophrenia
- Personal assistance for adults (19-64) with both physical and intellectual impairments
- Pharmaceutical interventions for emotionalism after stroke
- Pharmacologic Interventions for Pregnant Women Enrolled in Alcohol Treatment
- Pharmacologic treatment of depression in multiple sclerosis
- Pharmacological interventions for antisocial personality disorder
- Pharmacological interventions for benzodiazepine mono-dependence management in outpatient settings
- Pharmacological interventions for borderline personality disorder
- Pharmacological interventions for promoting smoking cessation during pregnancy
- Pharmacological interventions for the treatment of anxiety disorders in chronic obstructive pulmonary disease
- Pharmacological treatment for attention deficit hyperactivity disorder (ADHD) in children with comorbid tic disorders
- Pharmacological treatment for depression during opioid agonist treatment for opioid dependence
- Pharmacological treatment for memory disorder in multiple sclerosis
- Pharmacological treatment for psychotic depression
- Pharmacological treatment of hypertension in people without prior cerebrovascular disease for the prevention of cognitive impairment and dementia
- Pharmacological treatments for psychosis‐related polydipsia
- Pharmacological, psychological and non‐invasive brain stimulation interventions for preventing depression after stroke
- Pharmacological, psychological, and non‐invasive brain stimulation interventions for treating depression after stroke
The Cochrane Database of Systematic Reviews is considered the gold standard for evidence-based medicine. Essential Evidence Plus includes the latest and most up-to-date summaries of systematic reviews from the Cochrane Library, which are the most rigorous and reliable evaluations of medical therapies available. You’ll find summarized evaluations of the world’s best literature on the effectiveness of therapy for 3,300+ clinical problems.